A Randomized Trial of Amphotericin B alone or in combination with Itraconazole in the treatment of mucocutaneous Leishmaniasis

dc.contributor.author	Valda Rodríguez, Luis
dc.contributor.author	Dedet, Jean-Pierre
dc.contributor.author	Paredes, Virginia
dc.contributor.author	Mendoza, Carmelo
dc.contributor.author	Cárdenas, Fernando
dc.date.accessioned	2017-10-13T13:52:21Z
dc.date.available	2017-10-13T13:52:21Z
dc.date.issued	1995
dc.identifier.uri	http://repositorio.umsa.bo/xmlui/handle/123456789/12820
dc.description.abstract	A randomized trial of amphotericin B (AB) alone and in combination with oral itraconazole (IZ) is carried out in two groups of 10 mucocutaneous leishmaniasis patients from Bolivia and Perú. AB+IZ combination is no better than AB monotherapy as far as efficacy and tolerability are concerned. No antagonism was detected.	es_ES
dc.language.iso	en	es_ES
dc.publisher	Mem. Inst. Oswaldo Cruz	es_ES
dc.subject	LEISHMANIASIS MUCOCUTÁNEA	es_ES
dc.subject	TRATAMIENTO	es_ES
dc.subject	ANFOTERICINA B	es_ES
dc.subject	ITRACONAZOL	es_ES
dc.title	A Randomized Trial of Amphotericin B alone or in combination with Itraconazole in the treatment of mucocutaneous Leishmaniasis	es_ES
dc.type	Article	es_ES